======= SPOCK3 =======
== Gene Information ==
* **Official Symbol**: SPOCK3
* **Official Name**: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=50859|50859]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BQ16|Q9BQ16]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SPOCK3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPOCK3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607989|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of a novel family of calcium-binding proteoglycan proteins that contain thyroglobulin type-1 and Kazal-like domains. The encoded protein and may play a role in adult T-cell leukemia by inhibiting the activity of membrane-type matrix metalloproteinases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011].
* **UniProt Summary**: N/A
|SPARC Ca bdg|
|Kazal 2|
|Thyroglobulin 1|
|Kazal 1|
|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|
|metalloendopeptidase inhibitor activity|
|glycosaminoglycan binding|
|extracellular matrix binding|
|chondroitin sulfate metabolic process|
|chondroitin sulfate proteoglycan metabolic process|
|peptide cross-linking|
|collagen binding|
|proteoglycan metabolic process|
|mucopolysaccharide metabolic process|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|peptidyl-serine modification|
|negative regulation of endopeptidase activity|
|negative regulation of peptidase activity|
|negative regulation of cell motility|
|negative regulation of cellular component movement|
|negative regulation of locomotion|
|negative regulation of proteolysis|
|sulfur compound metabolic process|
|glycoprotein metabolic process|
|regulation of endopeptidase activity|
|regulation of peptidase activity|
|negative regulation of hydrolase activity|
|calcium ion binding|
|regulation of proteolysis|
|negative regulation of catalytic activity|
|peptidyl-amino acid modification|
|regulation of cell motility|
|regulation of locomotion|
|regulation of cellular component movement|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|negative regulation of cellular protein metabolic process|
|negative regulation of protein metabolic process|
|negative regulation of molecular function|
|regulation of hydrolase activity|
|extracellular space|
|small molecule metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.06|
|[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.74|
|[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|1.84|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18695
* **Expression level (log2 read counts)**: -2.69
{{:chemogenomics:nalm6 dist.png?nolink |}}